The Complex World of Drug Pricing
This event is open to all Columbia University students, alumni, faculty and staff. Reception to follow.
The cost of medicines is a major topic of concern for all healthcare stakeholders. It’s hard to look at the news without reading a story about a parent who can’t afford insulin for her child or a new “breakthrough” cancer drug that costs $850,000. Yet it's incredibly hard to understand the opaque world of drug pricing, its cost to the system and impact on patients. Therefore, we are convening a diverse set of healthcare industry stakeholders from across Columbia to help explain how pharma pricing works, the role of PBMs, the impact of patents - and how all of the inputs into this complicated structure ultimately impact prescribing decisions and patient outcomes.
- Tracy Bahl '04 – CEO of OneOncology; previously EVP, Health Plans at CVS Health
- Professor Neal Masia – Adjunct Professor of Business at Columbia Business School; formerly VP, Patient & Health Impact Center of Excellence at Pfizer
- Dr. Geraldine McGinty '00 – Chief Strategy and Contracting Officer; Assistant Professor Radiology and Healthcare Policy and Research at Weill Cornell Medicine
- Professor Bhaven Sampat – Associate Professor, Health Policy and Management, Mailman School of Public Health